Nurtec odt and Mobic drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Nurtec odt (rimegepant sulfate) and Mobic (meloxicam). Common drug interactions include anxiety among females.

The phase IV clinical study analyzes what interactions people have when they take Nurtec odt and Mobic. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Nurtec odt?

Nurtec odt has active ingredients of rimegepant sulfate. eHealthMe is studying from 9,221 Nurtec odt users. Check the latest studies of Nurtec odt.

What is Mobic?

Mobic has active ingredients of meloxicam. It is often used in arthritis. eHealthMe is studying from 26,684 Mobic users. Check the latest studies of Mobic.



On Aug, 11, 2026

13 people who take Nurtec odt and Mobic together, and have interactions are studied.

Nurtec odt and Mobic drug interactions.

What are the common drug interactions of Nurtec Odt and Mobic, by gender? *:

female:

  1. Anxiety
  2. Autism spectrum disorder (developmental disabilities that can cause significant social, communication and behavioural challenges)
  3. Nausea (feeling of having an urge to vomit)
  4. Neck pain
  5. Nephrolithiasis (calculi in the kidneys)
  6. Non-hodgkin's lymphoma (malignant (cancer) cells form in the lymph system)
  7. Seasonal allergy (allergic condition due to certain season)
  8. Sinusitis (inflammation of sinus)
  9. Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)
  10. Ulcer

male:

n/a

What are the common drug interactions of Nurtec Odt and Mobic, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Autism spectrum disorder (developmental disabilities that can cause significant social, communication and behavioural challenges)
  2. Constipation
  3. Ligament rupture (tear in ligament)
  4. Lower limb fracture
  5. Nephrolithiasis (calculi in the kidneys)
  6. Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)
  7. Ulcer
  8. Weight decreased
  9. Anxiety

40-49:

n/a

50-59:

  1. Bell's palsy (facial paralysis)
  2. Chronic kidney disease
  3. Facial paralysis (loss of function of face muscle)
  4. Inflammation

60+:

  1. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  2. Hypotension (abnormally low blood pressure)
  3. Chest pain
  4. Drug ineffective
  5. Rehabilitation therapy

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 4 people, 30.77%
  2. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 4 people, 30.77%
  3. Drowsiness: 4 people, 30.77%
  4. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 4 people, 30.77%
  5. Migraine (headache): 3 people, 23.08%
  6. Immunodeficiency Common Variable: 3 people, 23.08%
  7. Type 2 Diabetes: 1 person, 7.69%
  8. High Blood Pressure: 1 person, 7.69%
  9. High Blood Cholesterol: 1 person, 7.69%
  10. Asthma: 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Nurtec odt and Mobic?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Nurtec odt and Mobic:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Nurtec odt:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Mobic:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Nurtec odt and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Mobic and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on rimegepant sulfate and meloxicam (the active ingredients of Nurtec odt and Mobic, respectively), and Nurtec odt and Mobic (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: